By Mill Chart
Last update: Dec 1, 2025
For investors looking to find companies trading for less than their true worth, a disciplined screening method is necessary. One useful method is to find stocks that show an attractive valuation while also keeping good basic business health. This means looking past a low price-to-earnings ratio to confirm the company is also earning money, financially stable, and able to grow in the future. Stocks that satisfy this combined group of conditions can be especially notable for value-focused investors, as they might be situations where the market has not completely acknowledged a company's lasting earnings ability or market position.

Itron Inc (NASDAQ:ITRI) is a technology and services company that works on systems to measure, manage, and study energy and water use. Based in Liberty Lake, Washington, Itron works in areas such as Device Solutions (hardware products for measurement and control), Networked Solutions (full systems with smart meters and communication networks), and Outcomes (advanced software and data analysis services). A look at its basic profile indicates it could match the description of a stock priced below its worth with a firm operational base.
The central idea of value investing is buying a dollar of assets for fifty cents. Itron's valuation numbers indicate the market might be providing such a lower price. Based on ChartMill's basic analysis, Itron receives a Valuation Rating of 7 out of 10, showing a good price compared to its financial results and similar companies.
This combined information forms a view of a stock priced cautiously by the market. For a value investor, these numbers give a factual reason for thinking a "margin of safety" could be present.
A low-priced stock is only a worthwhile investment if the basic business is healthy. Itron's good profitability numbers help reduce the danger of a "value trap." The company has a high Profitability Rating of 8/10, indicating effective operations and good returns.
These numbers are vital for the value argument. They show that Itron is not just a weak company with a low stock price, but a profitable business with pricing ability and operational control. This quality backs the idea that its current market price may not show its real earnings potential.
Financial health makes sure a company can survive economic slowdowns and keep spending for future development. Itron's Health Rating is a middle 5/10, offering a varied but acceptable view. Value investors need to examine balance sheet strength to confirm a low-priced company is not also carrying too much debt.
While not the top in its field, Itron's financial health does not seem to be a major fault. The company creates enough cash flow to handle its debt, providing a stable base from which to run its plans.
For a value investment to reach its possibility, some part of growth or stabilization is often required. Itron's Growth Rating of 5/10 shows a company changing, with past difficulties making room for more hopeful predictions.
This growth outline is significant for the value approach. It suggests the company is not in a lasting condition of reduction but is set to expand into its valuation, possibly triggering a re-pricing by the market as future earnings appear.
Itron Inc offers an example in measured value investing. The stock trades at a clear discount to both its industry and the wider market based on several valuation numbers. Importantly, this low price is combined with clearly good profitability and a steadying growth view, which helps set it apart from a company in permanent trouble. While its financial health is middling, it is backed by strong cash flow production. For investors using a screen that looks for attractive value together with acceptable basics, Itron stands for the kind of candidate deserving of further careful study.
Interested in discovering more stocks that match this description? You can review other possible options using the Decent Value Stocks screen on ChartMill.
Disclaimer: This article is for information only and does not make up financial guidance, a suggestion, or an offer to buy or sell any securities. Investors should do their own study and talk with a qualified financial advisor before making any investment choices. The study is based on supplied information and may not be full or current.
96.24
+1.68 (+1.78%)
Find more stocks in the Stock Screener


